Accelera - Part of NMS Group

Accelera is one of the few Italian companies committed in preclinical research and offers integrated high level services for biotech and pharmaceutical companies, as well as academic Institutes and non-profit organizations, at a worldwide level. Accelera works in particularly in the field of assessment and profiling molecules in preclinical testing, their possible interactions with metabolism and their toxicity levels helping clients to "pick the best" drug candidates, right from the start. Thanks to its experienced researchers the company is able to offer a complete range of services and consultancy in different areas. Furthermore, a specific team specialised in Analytical Biology works in the field of bioanalytical and immunogenicity testing of various biological compounds. Accelera also offers support and advice in the development of New Chemical Entities and biological compounds and new cancer drugs, thanks to outstanding experience in the sector and in preclinical tumor models, PKPD, Attrition Reducing Technologies (ART), Drug Safety, bioanalysis and Regulatory Development. With over 25 integrated development programs executed in the last years, we are proud to be working with over 60 sponsors from Europe, North America and Asia. The reliability of results and their acceptability worldwide is guaranteed by different qualified scientific teams, advanced platforms and technologies located in a wide modular structure and high quality certification by Regulatory Agencies for Good Laboratory Practices (GLP) . Accelera experts are involved in the development and validation of innovative and alternative methods, in collaboration with most representative centers of reference and in teaching in higher education programme. Details on Accelera services and more info on expertise & capabilities on http://www.accelera.org/